Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001746473-25-000124
Filing Date
2025-06-09
Accepted
2025-06-09 20:42:49
Documents
2
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1749516160.html 4  
1 FORM 4 wk-form4_1749516160.xml 4 4205
2 EX-24 poa_crowell.txt EX-24 4341
  Complete submission text file 0001746473-25-000124.txt   10014
Mailing Address C/O HERCULES CAPITAL, INC. 1 NORTH B STREET, SUITE 2000 SAN MATEO CA 94401
Business Address
CROWELL GAYLE A (Reporting) CIK: 0001250893 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39303 | Film No.: 251035726

Mailing Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 331 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 650-481-6770
PLIANT THERAPEUTICS, INC. (Issuer) CIK: 0001746473 (see all company filings)

EIN.: 474272481 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)